Jay Rappaport
Impact in
- Virology top 0.2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Virology 80
- HIV Research and Treatment 80
-
- SARS-CoV-2 and COVID-19 Research 21
- COVID-19 Clinical Research Studies 9
- Co-authors
- Kamel Khalili (44 shared papers)Tracy Fischer (15 shared papers)Shohreh Amini (23 shared papers)Jean‐François Zagury (27 shared papers)Flossie Wong‐Staal (8 shared papers)Sidney E. Croul (7 shared papers)Prasun K. Datta (9 shared papers)Houria Hendel (16 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (12 papers)AIDS (7 papers)Journal of Biological Chemistry (7 papers)Journal of Virology (7 papers)Proceedings of the National Academy of Sciences (7 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Jay Rappaport
162 papers receiving 7k citations
Peers
Comparison fields: 5 of 124
- Virology 2.8k
- Infectious Diseases 1.1k
- Oncology 840
- Neurology 235
- Immunology 549
Countries citing papers authored by Jay Rappaport
This map shows the geographic impact of Jay Rappaport's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Rappaport with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Rappaport more than expected).
Fields of papers citing papers by Jay Rappaport
This network shows the impact of papers produced by Jay Rappaport. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Rappaport. The network helps show where Jay Rappaport may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay Rappaport, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 167 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 265 | |
| 2 | 1999 | 259 | |
| 3 | 2021 | 214 | |
| 4 | 2020 | 199 | |
| 5 | 1989 | 188 | |
| 6 | 1992 | 186 | |
| 7 | 1998 | 172 | |
| 8 | 1998 | 157 | |
| 9 | 1990 | 149 | |
| 10 | 1999 | 148 | |
| 11 | 2000 | 136 | |
| 12 | Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine. | 1999 | 132 |
| 13 | 2022 | 129 | |
| 14 | 2021 | 124 | |
| 15 | 2008 | 120 | |
| 16 | 1995 | 117 | |
| 17 | 2020 | 116 | |
| 18 | 2009 | 111 | |
| 19 | 2011 | 106 | |
| 20 | 2004 | 104 |
About Jay Rappaport
Jay Rappaport is a scholar working on Virology, Infectious Diseases, Oncology, Immunology and Molecular Biology, having authored 167 papers that have together received 7.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (80 papers), SARS-CoV-2 and COVID-19 Research (21 papers), Polyomavirus and related diseases (11 papers), COVID-19 Clinical Research Studies (9 papers), RNA Interference and Gene Delivery (5 papers), Genomics and Chromatin Dynamics (5 papers), HIV-related health complications and treatments (4 papers) and NF-κB Signaling Pathways (3 papers). The work is most often cited by research in Virology (2.8k citations), Infectious Diseases (1.1k citations), Oncology (840 citations), Neurology (235 citations) and Immunology (549 citations). Jay Rappaport has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Kamel Khalili, Tracy Fischer, Shohreh Amini, Jean‐François Zagury, Flossie Wong‐Staal, Sidney E. Croul, Prasun K. Datta, Houria Hendel, Daniel Zagury and Luis Del Valle. Their work appears in journals such as Biomedicine & Pharmacotherapy, AIDS, Journal of Biological Chemistry, Journal of Virology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.